Sensitive ASX Announcement

BOD to conduct Schedule 3 clinical trial of new CBD product

Published: 22/09/21, 09:14am (AEST)2 pages
Bod Science Limited
BOD:ASXHealthcare

Recent BOD Announcements

Price Sensitive only